2020年1月2日(ri),奇正(zheng)藏(zang)藥發布公告稱,奇正(zheng)藏(zang)藥公司與甘肅(su)省定西市(shi)臨洮(tao)縣人(ren)民政府簽(qian)訂戰略(lve)合(he)作框架協議,擬(ni)在(zai)臨洮(tao)縣投(tou)資建設(she)奇正(zheng)藏(zang)藥醫藥產業基(ji)地。
該項目總投資擬為11.99億元(yuan)人(ren)民幣(bi),總(zong)用地(di)面積約500畝。通(tong)過整合(he)現(xian)有奇正藏(zang)藥(yao)生產(chan)(chan)業務板(ban)塊,擬(ni)在臨洮縣洮陽鎮五愛(ai)村、西街(jie)村,建(jian)(jian)設(she)包(bao)括檢測中心綜合(he)大樓、生產(chan)(chan)車間、生產(chan)(chan)附(fu)屬建(jian)(jian)筑設(she)施(shi)、職工宿舍等建(jian)(jian)筑物,建(jian)(jian)成(cheng)投產(chan)(chan)后將成(cheng)為奇正藏(zang)藥(yao)主要生產(chan)(chan)基地。
奇正藏藥1995年落戶西藏林芝,根(gen)植民族地區(qu)20余年,我(wo)們(men)的運營(ying)、我(wo)們(men)的員工、我(wo)們(men)的產(chan)品與(yu)這里的社區(qu)、環境(jing)和人息(xi)息(xi)相(xiang)關(guan),水乳交(jiao)融。從光彩(cai)事業(ye)到社會責任,我(wo)們(men)堅持始終如一的核心(xin)價值觀:“ 向(xiang)善利(li)他,正道正業(ye) ” 。我(wo)們(men)正向(xiang)追求健康(kang)和財富,在(zai)工作行為(wei)及個人內(nei)心(xin),始終保(bao)持動機與(yu)發心(xin)的善念,在(zai)不斷滿足并超(chao)越消費者期望的過(guo)程中(zhong),在(zai)推(tui)動與(yu)合作伙伴深度協作、價值認同的過(guo)程中(zhong),實現(xian)企業(ye)價值。
藏(zang)醫(yi)藥(yao)(yao)被譽為東方(fang)文(wen)明和(he)智慧(hui)的(de)“種(zhong)質資源”,經(jing)過兩(liang)千多年(nian)的(de)傳承,上萬種(zhong)安全穩定、療(liao)效確(que)切的(de)組(zu)方(fang)被保(bao)存下來。截(jie)止2019年(nian)底(di),奇正藏(zang)藥(yao)(yao)有55個(ge)(ge)藏(zang)藥(yao)(yao)品(pin)(pin)(pin)名(ming)和(he)72個(ge)(ge)藥(yao)(yao)品(pin)(pin)(pin)批準(zhun)文(wen)號,其中1個(ge)(ge)品(pin)(pin)(pin)種(zhong)進入(ru)(ru)(ru)國(guo)家(jia)基(ji)本藥(yao)(yao)物目錄(lu),17個(ge)(ge)品(pin)(pin)(pin)種(zhong)進入(ru)(ru)(ru)《國(guo)家(jia)基(ji)本醫(yi)療(liao)保(bao)險、工(gong)傷(shang)保(bao)險和(he)生育保(bao)險藥(yao)(yao)品(pin)(pin)(pin)目錄(lu)(2019年(nian)版)》,35個(ge)(ge)產品(pin)(pin)(pin)進入(ru)(ru)(ru)地方(fang)省級醫(yi)保(bao)目錄(lu),49個(ge)(ge)產品(pin)(pin)(pin)進入(ru)(ru)(ru)地方(fang)基(ji)藥(yao)(yao)目錄(lu),9個(ge)(ge)產品(pin)(pin)(pin)進入(ru)(ru)(ru)地方(fang)低(di)價藥(yao)(yao)目錄(lu),2個(ge)(ge)產品(pin)(pin)(pin)進入(ru)(ru)(ru)國(guo)家(jia)急(搶)救藥(yao)(yao)品(pin)(pin)(pin)目錄(lu)。這些藥(yao)(yao)品(pin)(pin)(pin)包括消(xiao)痛貼膏、青鵬軟膏、白脈軟膏等外用藥(yao)(yao)及(ji)紅花(hua)如意丸(wan)、仁青芒覺膠囊、潔白丸(wan)等口服藥(yao)(yao),涉(she)及(ji)骨科(ke)(ke)、神經(jing)科(ke)(ke)、婦科(ke)(ke)、消(xiao)化科(ke)(ke)等多個(ge)(ge)藏(zang)醫(yi)特(te)色(se)治療(liao)領(ling)域(yu)。
從(cong)運用(yong)(yong)低溫真空冷凍(dong)干燥技術(shu)把傳統的(de)(de)糊狀黑膏藥(yao)(yao)(yao)變(bian)成(cheng)現(xian)代濕敷(fu)貼劑并帶入內地市場開始,奇(qi)正藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)始終專注于藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)產(chan)業的(de)(de)現(xian)代化,通過科研(yan)(yan)創(chuang)新、技術(shu)創(chuang)新、營銷創(chuang)新,讓古老(lao)的(de)(de)藏(zang)(zang)(zang)(zang)醫(yi)(yi)(yi)藥(yao)(yao)(yao)在現(xian)代社(she)會(hui)發(fa)(fa)揮更大(da)(da)的(de)(de)價(jia)值。2019年,公司承接國家(jia)“中(zhong)醫(yi)(yi)(yi)藥(yao)(yao)(yao)現(xian)代化研(yan)(yan)究”重(zhong)點專項中(zhong)的(de)(de)“藏(zang)(zang)(zang)(zang)醫(yi)(yi)(yi)藥(yao)(yao)(yao)防治(zhi)重(zhong)大(da)(da)疾(ji)病(bing)(bing)(bing)或(huo)優勢病(bing)(bing)(bing)種的(de)(de)藥(yao)(yao)(yao)物研(yan)(yan)究”,項目(mu)(mu)名稱為“經典(dian)藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)如意珍寶片和白(bai)脈(mo)軟膏治(zhi)療藏(zang)(zang)(zang)(zang)醫(yi)(yi)(yi)重(zhong)大(da)(da)疾(ji)病(bing)(bing)(bing)白(bai)脈(mo)病(bing)(bing)(bing)的(de)(de)示(shi)范開發(fa)(fa)研(yan)(yan)究”。該項目(mu)(mu)集(ji)結國內優勢研(yan)(yan)究力量,建(jian)立了藏(zang)(zang)(zang)(zang)醫(yi)(yi)(yi)理論(lun)、藥(yao)(yao)(yao)理機制(zhi)(zhi)和循證醫(yi)(yi)(yi)學三位一體(ti)(ti)(ti)的(de)(de)臨床(chuang)定位研(yan)(yan)究體(ti)(ti)(ti)系;構建(jian)起內調外(wai)治(zhi)安全(quan)性和有效性的(de)(de)作用(yong)(yong)機制(zhi)(zhi)和臨床(chuang)評價(jia)方法;運用(yong)(yong)國內專業的(de)(de)工藝(yi)技術(shu)和質控(kong)(kong)指標(biao)解(jie)決滅菌和粒度(du)超標(biao)等藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)生(sheng)產(chan)技術(shu)難(nan)題等,同(tong)時也是醫(yi)(yi)(yi)、產(chan)、學、研(yan)(yan)一體(ti)(ti)(ti),藏(zang)(zang)(zang)(zang)中(zhong)西(xi)(xi)相結合圍繞挖掘(jue)藏(zang)(zang)(zang)(zang)醫(yi)(yi)(yi)藥(yao)(yao)(yao)治(zhi)療優勢探索(suo)神經系統重(zhong)大(da)(da)疾(ji)病(bing)(bing)(bing)解(jie)決方案而展開的(de)(de)課(ke)題。同(tong)年,奇(qi)正藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)下屬林芝(zhi)制(zhi)(zhi)造(zao)(zao)中(zhong)心(xin)(xin)《基于自主核心(xin)(xin)智能裝(zhuang)備的(de)(de)藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)外(wai)用(yong)(yong)制(zhi)(zhi)劑智能工廠(chang)建(jian)設項目(mu)(mu)》改擴建(jian)工程順利完工,項目(mu)(mu)旨(zhi)在建(jian)成(cheng)集(ji)生(sheng)產(chan)自動控(kong)(kong)制(zhi)(zhi)、調度(du)、管理和經營決策于一體(ti)(ti)(ti)的(de)(de)藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)外(wai)用(yong)(yong)制(zhi)(zhi)劑智能工廠(chang)。未(wei)來,林芝(zhi)制(zhi)(zhi)造(zao)(zao)中(zhong)心(xin)(xin)將為西(xi)(xi)藏(zang)(zang)(zang)(zang)藏(zang)(zang)(zang)(zang)藥(yao)(yao)(yao)企(qi)業的(de)(de)數(shu)字化、智能化轉型(xing)升級提供示(shi)范。
民族(zu)藥(yao)(yao)的(de)(de)一大特點是(shi)以植(zhi)物藥(yao)(yao)材(cai)入藥(yao)(yao),且(qie)產業多(duo)位于中西部地(di)(di)(di)區(qu)。奇(qi)正藏(zang)藥(yao)(yao)在多(duo)年(nian)的(de)(de)發(fa)(fa)展(zhan)(zhan)中,積(ji)極實踐(jian)原(yuan)(yuan)產地(di)(di)(di)可持(chi)續供(gong)應鏈管理,注(zhu)重資源環(huan)境的(de)(de)保護性開(kai)發(fa)(fa),專(zhuan)注(zhu)于民族(zu)地(di)(di)(di)區(qu)的(de)(de)人才培養,建設著眼于長遠利益的(de)(de)商業生(sheng)(sheng)(sheng)態系統。公(gong)(gong)司(si)持(chi)續開(kai)展(zhan)(zhan)藏(zang)藥(yao)(yao)材(cai)資源調(diao)(diao)查工(gong)(gong)作,積(ji)極實踐(jian)野生(sheng)(sheng)(sheng)資源不足品(pin)種(zhong)(zhong)(zhong)的(de)(de)家(jia)種(zhong)(zhong)(zhong)化,穩(wen)步推(tui)進多(duo)個藏(zang)藥(yao)(yao)材(cai)在原(yuan)(yuan)生(sheng)(sheng)(sheng)環(huan)境下的(de)(de)野生(sheng)(sheng)(sheng)、半野生(sheng)(sheng)(sheng)及人工(gong)(gong)撫育馴化種(zhong)(zhong)(zhong)植(zhi)研究(jiu)。截止2019年(nian)底,公(gong)(gong)司(si)有(you)各類藏(zang)藥(yao)(yao)材(cai)野生(sheng)(sheng)(sheng)撫育基(ji)地(di)(di)(di)109436畝; 公(gong)(gong)司(si)從原(yuan)(yuan)產地(di)(di)(di)采(cai)(cai)購的(de)(de)原(yuan)(yuan)藥(yao)(yao)材(cai)數量(liang)占比達(da)70%; 公(gong)(gong)司(si)歷年(nian)開(kai)展(zhan)(zhan)人工(gong)(gong)種(zhong)(zhong)(zhong)植(zhi)技術(shu)研究(jiu)的(de)(de)藏(zang)藥(yao)(yao)材(cai)品(pin)種(zhong)(zhong)(zhong)已達(da)52種(zhong)(zhong)(zhong)。奇(qi)正藏(zang)藥(yao)(yao)普查隊在平(ping)均海拔5000米的(de)(de)藏(zang)區(qu)完成對72個樣(yang)地(di)(di)(di)、360個樣(yang)方套、2160樣(yang)方的(de)(de)調(diao)(diao)查,行程22000公(gong)(gong)里,樣(yang)地(di)(di)(di)到達(da)率符合國家(jia)考(kao)核標準,且(qie)遠超西藏(zang)大多(duo)數普查隊伍(wu),采(cai)(cai)集標本約450號(hao)約3500份,超出考(kao)察(cha)地(di)(di)(di)原(yuan)(yuan)紀錄約180種(zhong)(zhong)(zhong),發(fa)(fa)現(xian)重點品(pin)種(zhong)(zhong)(zhong)4種(zhong)(zhong)(zhong),拍攝照片7000余(yu)張。2019年(nian),公(gong)(gong)司(si)聯合WTO 經濟導刊(kan)發(fa)(fa)布(bu)《金(jin)蜜蜂全球CSR2030倡議進展(zhan)(zhan)報告》,旨在關注(zhu)藏(zang)藥(yao)(yao)開(kai)發(fa)(fa)和保護高原(yuan)(yuan)生(sheng)(sheng)(sheng)物多(duo)樣(yang)性。
奇正藏(zang)(zang)(zang)藥(yao)(yao)扎根藏(zang)(zang)(zang)區,專注于以長效機制反哺藏(zang)(zang)(zang)區、實(shi)現與(yu)西藏(zang)(zang)(zang)的(de)共同(tong)進(jin)步(bu)。在(zai)多年(nian)的(de)實(shi)踐(jian)中,奇正藏(zang)(zang)(zang)藥(yao)(yao)形成了具備(bei)自身特點(dian)的(de)藏(zang)(zang)(zang)文化(hua)保(bao)護與(yu)傳(chuan)承方式:重建(jian)五明文化(hua)學院,出版大師典籍,保(bao)持源頭活水; 舉辦傳(chuan)統藏(zang)(zang)(zang)醫(yi)學校,培(pei)養傳(chuan)承與(yu)復興人才; 捐(juan)建(jian)藏(zang)(zang)(zang)醫(yi)診所,開展(zhan)藏(zang)(zang)(zang)醫(yi)診療,保(bao)持文化(hua)的(de)生(sheng)命(ming)力; 在(zai)自有產(chan)業基地(di)建(jian)設(she)藏(zang)(zang)(zang)醫(yi)藥(yao)(yao)文化(hua)展(zhan)廳,展(zhan)示、傳(chuan)播藏(zang)(zang)(zang)醫(yi)藥(yao)(yao)文化(hua)。同(tong)時,奇正藏(zang)(zang)(zang)藥(yao)(yao)也專注于慈善公益事(shi)業,截止2019年(nian)底,奇正藏(zang)(zang)(zang)藥(yao)(yao)已累計投入1.2億余元用(yong)于藏(zang)(zang)(zang)區和西部的(de)醫(yi)療、教(jiao)育、扶貧等社會(hui)公益事(shi)業。
維生(sheng)素是維持我們(men)人體的身(shen)體健康所必需的一種有機(ji)化(hua)合物,在(zai)人體的新陳(chen)代謝(xie)中起著重要的作(zuo)用。維...
李(li)楚源,中(zhong)山大(da)學(xue)化(hua)學(xue)系化(hua)學(xue)專業本科畢(bi)業,擁有中(zhong)山大(da)學(xue)嶺南EMBA碩(shuo)士(shi)學(xue)位。現任廣州(zhou)醫(yi)藥集團(tuan)...
任晉生,國(guo)(guo)家科技(ji)進步二等獎、全國(guo)(guo)五一勞動(dong)獎章獲(huo)得者。現任江蘇先聲藥業有限公(gong)司創始人、董事長...
李安平,中國社會科學院研究生(sheng)院企業管理專(zhuan)業畢業,碩士學歷,高級經(jing)濟(ji)師,長治市(shi)第十一屆(jie)人(ren)大代...